Literature DB >> 7509070

Growth hormone (GH) induces tyrosine-phosphorylated proteins in mouse L cells that express recombinant GH receptors.

X Wang1, B Xu, S C Souza, J J Kopchick.   

Abstract

Porcine and bovine GH receptor (GHR) cDNAs were stably expressed in mouse L cells, which normally do not possess detectable levels of mouse GHR. Expression of the GHR cDNAs resulted in specific binding of 125I-labeled GH by these cell lines. To study GHR-related signaling events in these cells, protein tyrosine phosphorylation was examined. In GH-treated cells, a tyrosine-phosphorylated protein with a molecular mass of approximately 95 kDa (pp95) was increased dramatically (approximately 100-fold) relative to non-GH-treated cells. The amount of pp95 within the cells after GH treatment was positively correlated with the number of GHRs on the cells. Tyrosine phosphorylation of pp95 could not be induced by prolactin, insulin, insulin-like growth factor I, interleukin 2, epidermal growth factor, platelet-derived growth factor, or fibroblast growth factor. Phosphorylation of pp95 was found to be a rapid event that could be observed 60 sec after GH treatment. Also, pp95 appears to exist as a complex of two proteins, i.e., pp95 and pp96. The GH-induced response by these cells may be of use in screening GH analogs for biological activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7509070      PMCID: PMC43164          DOI: 10.1073/pnas.91.4.1391

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  The prolactin/growth hormone receptor family.

Authors:  P A Kelly; J Djiane; M C Postel-Vinay; M Edery
Journal:  Endocr Rev       Date:  1991-08       Impact factor: 19.871

2.  Up-regulation of vinculin expression in 3T3 preadipose cells by growth hormone.

Authors:  S Guller; R E Corin; K Yuan-Wu; M Sonenberg
Journal:  Endocrinology       Date:  1991-07       Impact factor: 4.736

3.  Evidence for a rapid stimulation of tyrosine kinase activity by prolactin in Nb2 rat lymphoma cells.

Authors:  J A Rillema; G S Campbell; D M Lawson; C Carter-Su
Journal:  Endocrinology       Date:  1992-08       Impact factor: 4.736

4.  Growth hormone (GH) stimulates protein synthesis in cells transfected with GH receptor complementary DNA.

Authors:  M Emtner; L S Mathews; G Norstedt
Journal:  Mol Endocrinol       Date:  1990-12

5.  A growth hormone (GH) analog can antagonize the ability of native GH to promote differentiation of 3T3-F442A preadipocytes and stimulate insulin-like and lipolytic activities in primary rat adipocytes.

Authors:  S Okada; W Y Chen; P Wiehl; B Kelder; H M Goodman; S Guller; M Sonenberg; J J Kopchick
Journal:  Endocrinology       Date:  1992-04       Impact factor: 4.736

6.  Growth hormone induces expression of c-jun and jun B oncogenes and employs a protein kinase C signal transduction pathway for the induction of c-fos oncogene expression.

Authors:  M C Slootweg; R P de Groot; M P Herrmann-Erlee; I Koornneef; W Kruijer; Y M Kramer
Journal:  J Mol Endocrinol       Date:  1991-04       Impact factor: 5.098

7.  Stimulation by growth hormone (GH) of GH receptor-associated tyrosine kinase activity.

Authors:  S E Stred; J R Stubbart; L S Argetsinger; W C Smith; J A Shafer; F Talamantes; C Carter-Su
Journal:  Endocrinology       Date:  1992-03       Impact factor: 4.736

8.  Growth hormone stimulates the tyrosine phosphorylation of 42- and 45-kDa ERK-related proteins.

Authors:  L A Winston; P J Bertics
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

9.  Growth hormone activates mitogen-activated protein kinase and S6 kinase and promotes intracellular tyrosine phosphorylation in 3T3-F442A preadipocytes.

Authors:  N G Anderson
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

10.  Stimulation by growth hormone of MAP kinase activity in 3T3-F442A fibroblasts.

Authors:  G S Campbell; L Pang; T Miyasaka; A R Saltiel; C Carter-Su
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

View more
  3 in total

Review 1.  Pegvisomant: a growth hormone receptor antagonist used in the treatment of acromegaly.

Authors:  Nicholas A Tritos; Beverly M K Biller
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

2.  Differential in vivo activities of bovine growth hormone analogues.

Authors:  J Kopchick; X Z Chen; Y Li; R W Steger; J S Yun; T E Wagner; A Bartke
Journal:  Transgenic Res       Date:  1998-01       Impact factor: 2.788

3.  A single arginine residue determines species specificity of the human growth hormone receptor.

Authors:  S C Souza; G P Frick; X Wang; J J Kopchick; R B Lobo; H M Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.